OXYGEN
06/06/2005, 15h38
2nd use OK'd for Viagra-based drug
FDA approves Pfizer's Revatio, with same agent as Viagra, to treat a rare hypertension disease.
June 6, 2005: 9:43 AM EDT
NEW YORK (CNN/Money) - The Food and Drug Administration approved Revatio, a treatment for pulmonary arterial hypertension that uses the same active ingredient as Viagra, said Pfizer Inc. on Monday.
The active ingredient, sildenafil citrate, would be used in Revatio to fight a rare, aggressive and life-shortening vascular disease, known as PAH, which affects about 100,000 people worldwide. Untreated patients with PAH, which causes high pressure in blood vessels leading from the heart to the lungs, have an average survival time of less than three years following diagnosis, the company said.
Sildenafil citrate is also the ingredient in Viagra, an erectile dysfunction drug also made by Pfizer and used by more than 26 million men worldwide.
FDA approves Pfizer's Revatio, with same agent as Viagra, to treat a rare hypertension disease.
June 6, 2005: 9:43 AM EDT
NEW YORK (CNN/Money) - The Food and Drug Administration approved Revatio, a treatment for pulmonary arterial hypertension that uses the same active ingredient as Viagra, said Pfizer Inc. on Monday.
The active ingredient, sildenafil citrate, would be used in Revatio to fight a rare, aggressive and life-shortening vascular disease, known as PAH, which affects about 100,000 people worldwide. Untreated patients with PAH, which causes high pressure in blood vessels leading from the heart to the lungs, have an average survival time of less than three years following diagnosis, the company said.
Sildenafil citrate is also the ingredient in Viagra, an erectile dysfunction drug also made by Pfizer and used by more than 26 million men worldwide.